Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis

BACKGROUND: Ewing sarcoma patients have a poor prognosis despite multimodal therapy. Integration of combination immunotherapeutic strategies into first-/second-line regimens represents promising treatment options, particularly for patients with intrinsic or acquired resistance to conventional therap...

詳細記述

保存先:
書誌詳細
主要な著者: Berghuis, Dagmar, Schilham, Marco W, Vos, Hanneke I, Santos, Susy J, Kloess, Stephan, Buddingh', Emilie P, Egeler, R Maarten, Hogendoorn, Pancras CW, Lankester, Arjan C
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2012
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351702/
https://ncbi.nlm.nih.gov/pubmed/22587892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-2-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料